ImmuCell Corporation

ImmuCell Corporation is a growing animal health company that develops, manufactures and markets scientifically-proven products that improve health and productivity in the dairy and beef industries. The Company develops, manufactures and markets the First Defense® product line that provides “immediate immunity” against aggressive pathogens, including E. coli, coronavirus, and rotavirus in newborn dairy and beef calves without the use of traditional antibiotics. ImmuCell holds a unique position, they are the only animal health company with the ability to concentrate, purify, and quantify specific colostrum antibodies (E. coli, coronavirus, and rotavirus) on a commercial scale. This reduces the amount of antibiotics in the human food chain and it maximizes the productive capabilities of dairy and beef producers future operating assets – their newborn calves.

Bank Name ImmuCell Corporation
Stock Exchange NASDAQ
Symbol ICCC
Sector Healthcare
Industry Biotechnology: In Vitro
Country United States
World Region Amarica
CEO Mr. Michael F. Brigham
Employees 43
Registered Year 1982